peg-asparaginase
Showing 1 - 18 of 18
Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)
Recruiting
- Acute Lymphoid Leukemia
- +3 more
- Prednisone
- +9 more
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Jul 24, 2023
Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,
Completed
- Refractory Acute Lymphoblastic Leukemia
- Relapsed Acute Lymphoblastic Leukemia
- Pevonedistat
- +7 more
-
Miami, FloridaUniversity of Miami
Oct 19, 2022
Acute Lymphoblastic Leukemia Trial in Canada, United States (Doxorubicin, Cytarabine, Methotrexate)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- Doxorubicin
- +13 more
-
Boston, Massachusetts
- +14 more
Jul 25, 2022
Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)
Recruiting
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Rituximab
- +18 more
-
Frankfurt (Main), GermanyUniversity Hospital of Frankfurt (Main)
Jul 1, 2022
Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)
Completed
- Acute Lymphoblastic Leukemia
- Everolimus
- +5 more
-
San Francisco, California
- +7 more
Aug 5, 2022
Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia Trial in United States (ABT-751, Dexamethasone,
Terminated
- Recurrent Pediatric ALL
- +3 more
- ABT-751
- +7 more
-
Los Angeles, California
- +4 more
Feb 22, 2021
Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Carfilzomib, Dexamethasone, Mitoxantrone)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- Carfilzomib
- +10 more
-
Orange, California
- +86 more
Nov 14, 2022
Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Houston (Daunorubicin, Vincristine, PEG-asparaginase)
Completed
- Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Daunorubicin
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 21, 2019
Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, T Cell Trial in
Terminated
- Lymphoblastic Leukemia, Acute
- +3 more
- EZN-3042
- +7 more
-
Los Angeles, California
- +6 more
May 21, 2019
Acute Lymphoblastic Leukemia, Lymphoma, Non-Hodgkin's, Leukemia, T-Cell Trial in Memphis (Dexamethasone, Panobinostat, Liposomal
Terminated
- Acute Lymphoblastic Leukemia
- +3 more
- Dexamethasone
- +13 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Mar 8, 2019
Acute Lymphoblastic Leukemia Trial in Worldwide (Bortezomib, Dexamethasone, PEG-asparaginase)
B-cell Adult Acute Lymphoblastic Leukemia (ALL), Ph-positive Adult Acute Lymphoblastic Leukemia (ALL), Recurrent Adult Acute
Completed
- B-cell Adult Acute Lymphoblastic Leukemia (ALL)
- +3 more
- Bortezomib
- +6 more
-
Stanford, CaliforniaStanford University, School of Medicine
Oct 14, 2018
Acute Lymphoblastic Leukemia Trial in Boston (Prednisone, Vincristine, Doxorubicin)
Completed
- Acute Lymphoblastic Leukemia
- Prednisone
- +8 more
-
Boston, Massachusetts
- +2 more
Feb 10, 2017
Acute Lymphoblastic Leukemia Trial in Atlanta (Sirolimus, PEG-asparaginase)
Withdrawn
- Acute Lymphoblastic Leukemia
- Sirolimus
- PEG-asparaginase
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Nov 30, 2013
Acute Lymphoblastic Leukemia Trial in Aarhus (PEG-asparaginase)
Unknown status
- Acute Lymphoblastic Leukemia
- PEG-asparaginase
-
Aarhus, Aarhus N, DenmarkDepartment of Pediatrics, Skejby Hospital
Sep 29, 2009